IE 11 is not supported. For an optimal experience visit our site on another browser.

Revolutions Medical Agrees to General Terms and Signs Agreement for Manufacturing of RevVac 3cc Safety Syringe

/ Source: GlobeNewswire

CHARLESTON, S.C., Sept. 3, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB:RMCP) signs Letter of Intent today with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe. The final terms are expected to be completed in definitive documents between the parties no later than September 17th, 2010.

The agreed upon general terms provide for the manufacturing of 5 million syringes per month and can allow an increase of up to 20 million syringes per month. MIG has both domestic and international manufacturing capabilities.

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.

For additional information, please visit Revolutions Medical corporate website:

Investor Resource Center

RevVac Safety Syringe Demonstration Video:

RevColor MRI Video:

To be added to the Revolutions Medical investor email list, please email with RMCP in the subject line.

Become a RevMed fan and follow the Company on Facebook -- visit


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

CONTACT: Revolutions Medical Corporation Investor Relations: Scott Key (843) 518-0437